Literature DB >> 11502489

Molecular pathogenesis of pneumococcal pneumonia.

J A McCullers1, E I Tuomanen.   

Abstract

The past two decades have witnessed an explosion of data on the molecular pathogenesis of pneumonia caused by Streptococcus pneumoniae, one of the most important pathogens currently plaguing man. Identification and functional analysis of genes and their proteins, elucidation of mechanisms involved in adherence, colonization, inflammation, and invasion, and an understanding of interactions with the host and with external factors have provided knowledge that can be used to attack this organism with small molecule or vaccine based strategies. Study of the pneumococcus has also led to insights into other pathogens that share a unique spectrum of respiratory disease. In this review we will discuss recent advances in our understanding of the pathogenesis of pneumonia due to S. pneumoniae, highlighting emerging themes common to other organisms such as Haemophilus influenzae and Neisseria meningitidis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502489     DOI: 10.2741/mccullers

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  51 in total

1.  A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice.

Authors:  Paul Denny; Elaine Hopes; Neill Gingles; Karl W Broman; William McPheat; John Morten; Janet Alexander; Peter W Andrew; Steve D M Brown
Journal:  Mamm Genome       Date:  2003-07       Impact factor: 2.957

2.  Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection.

Authors:  Maria Hedlund; Laura M Aschenbrenner; Kellie Jensen; Jeffrey L Larson; Fang Fang
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

3.  Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae.

Authors:  Hongwei Zhou; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

4.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.

Authors:  Julie L McAuley; Felicita Hornung; Kelli L Boyd; Amber M Smith; Raelene McKeon; Jack Bennink; Jonathan W Yewdell; Jonathan A McCullers
Journal:  Cell Host Microbe       Date:  2007-10-11       Impact factor: 21.023

5.  A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.

Authors:  Philippe Denoël; Mario T Philipp; Lara Doyle; Dale Martin; Georges Carletti; Jan T Poolman
Journal:  Vaccine       Date:  2011-05-30       Impact factor: 3.641

6.  Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development.

Authors:  Muna F Abry; Kelvin M Kimenyi; Fred O Osowo; Willingtone O Odhiambo; Steven O Sewe; Benard W Kulohoma
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  IL-10-producing NK cells exacerbate sublethal Streptococcus pneumoniae infection in the lung.

Authors:  Sarah E Clark; Rebecca L Schmidt; Elizabeth R Aguilera; Laurel L Lenz
Journal:  Transl Res       Date:  2020-07-04       Impact factor: 7.012

8.  Cytosolic Phospholipase A2α Promotes Pulmonary Inflammation and Systemic Disease during Streptococcus pneumoniae Infection.

Authors:  Rudra Bhowmick; Stacie Clark; Joseph V Bonventre; John M Leong; Beth A McCormick
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 9.  Secondary bacterial infections in influenza virus infection pathogenesis.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 10.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.